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Abstract 
Attention deficit/hyperactivity disorder (ADHD) is a risk factor for tobacco use and dependence. This 
study examines the responsiveness to nicotine of an adolescent model of ADHD, the spontaneously 
hypertensive rat (SHR). The conditioned place preference (CPP) procedure was used to assess 
nicotine-induced locomotion and conditioned reward in SHR and the Wistar Kyoto (WKY) control 
strain over a range of nicotine doses (0.0, 0.1, 0.3 and 0.6 mg/kg). Prior to conditioning, SHRs were 
more active and less biased towards one side of the CPP chamber than WKY rats. Following 
conditioning, SHRs developed CPP to the highest dose of nicotine (0.6 mg/kg), whereas WKYs did 
not develop CPP to any nicotine dose tested. During conditioning, SHRs displayed greater locomotor 
activity in the Nicotine-Paired compartment than in the Saline-Paired compartment across 
conditioning trials. SHRs that received nicotine (0.1, 0.3, 0.6 mg/kg) in the Nicotine-Paired 
compartment showed an increase in locomotor activity between conditioning trials. Nicotine did not 
significantly affect WKY locomotor activity. These findings suggest that the SHR strain is a suitable 
model for studying ADHD-related nicotine use and dependence, but highlights potential limitations of 
the WKY control strain and the CPP procedure for modeling ADHD-related nicotine reward.  
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Vulnerability to tobacco dependence is heightened during adolescence [1]. Several factors are 
associated with increased risk of adolescent smoking, including low socioeconomic status, peer 
smoking, parental smoking, risk taking, and comorbid psychopathology [1].  Psychopathologies 
associated with adolescent smoking include anxiety disorders, depressive disorders, conduct 
disorders and attention-deficit hyperactivity disorder (ADHD) [2].  
ADHD is a developmental neurobehavioral disorder characterized by excessive levels of 
hyperactivity, inattention, and impulsivity [3], and is a risk factor for tobacco use and dependence [4].  
The prevalence of cigarette smoking among adolescents and adults with ADHD is nearly double that 
of their non-diagnosed peers [5–7].  Adolescent smokers with ADHD first experiment with tobacco 
and progress to regular use at a younger age than non-ADHD adolescent smokers [8]. Furthermore, 
adolescent smokers with ADHD are more likely to become tobacco dependent and to continue 
smoking into adulthood than non-ADHD adolescent smokers [5,7,8]. Once dependent, individuals 
with ADHD have greater difficulty quitting and exhibit more severe withdrawal symptoms than non-
ADHD smokers [9,10].  
The subjective experience of smoking and in the motivational factors that contribute to 
smoking appear to covary with ADHD status [11,12]. Specifically, smokers with ADHD report that 
smoking is more calming, reinforcing, and provides greater cognitive enhancement; they also report 
greater satisfaction and liking of cigarette puffs [12].  Smokers with ADHD report experiencing 
smoking-related cues more frequently than non-ADHD smokers, which may indicate that those cues 
acquire greater motivational or attentional salience for ADHD-smokers [11]. These studies suggest 
that ADHD is linked to a heightened sensitivity to smoking-related reward and smoking-related cues. 
The present study experimentally tested this hypothesis using an animal model of ADHD, the 
spontaneously hypertensive rat (SHR).  
The SHR is the most validated animal model of ADHD, displaying symptoms of inattentiveness 
[13], impulsivity [14],  and hyperactivity [15,16]. These symptoms have been established by 
comparing SHR behavior against the behavior of its progenitor control, the Wistar Kyoto (WKY) rat 
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[17]. Thus, inferences regarding ADHD-related behaviors drawn from SHRs ideally require 
comparison to the WKY reference strain. Prior studies have shown that SHRs self-administer nicotine 
at a higher rate than many other rat strains, including the WKY [18]. The present study aimed at 
providing converging evidence of heightened sensitivity to the rewarding effects of nicotine in SHR 
using the conditioned place preference procedure (CPP), a Pavlovian measure of conditioned drug 
reward [19]. Thus, nicotine-induced locomotion and preference for a nicotine-paired context served as 
measures of sensitivity to nicotine [20,21].  
Ninety-two experimentally naïve adolescent male spontaneously hypertensive rats (SHR/NCrl; 
Charles River Laboratories, US; n =44) and Wistar Kyoto rats (WKY/NHsd; Harlan Laboratories, US; 
n = 48) were used. SHR weights ranged from 57-83 g and WKY weights ranged from 56-87 g upon 
arrival.  All rats arrived in the colony room on postnatal day (PND) 24 and were immediately pair-
housed and provided ad libitum access to food and water in their home cages. All animals were 
handled for at least 2 minutes per day prior to the beginning of experimentation. Animals were 
housed in a colony room maintained on a 12:12 hr light:dark cycle with lights on at 1900 h. Behavioral 
testing was conducted only during the dark phase. All procedures were conducted in accordance with 
the guidelines described in the 8th edition of the Guide for the Care and Use of Laboratory Animals, 
and were approved by the Institutional Animal Care and Use Committee at Arizona State University. 
The experiment was conducted in three identical place-conditioning chambers (Med 
Associates, St. Albans, VT) (53.3 x 34.3 x 1.3 cm), which were interfaced to a PC computer that 
recorded animal activity and location in the apparatus. Test chambers were divided into two equally-
sized compartments separated by an manual acrylic guillotine door. Compartments were equipped 
with stainless steel grid floors and white stimulus lights located on the outside walls of both 
compartments. Exterior walls of the apparatus were made of clear Plexiglas. Black and white striped 
paper was arranged in opposite directions (vertical vs. horizontal stripes) on the outside of the walls 
to make the interior of the compartments visually distinct. A stainless steel pan was located beneath 
the grid floor of the chamber. Sanichip bedding was placed on one side of the pan and was separated 
 5 
from corncob bedding placed on the opposite side to provide distinct olfactory cues. Locomotor 
activity was monitored by 16 pairs of photobeams (8 per side) spaced evenly along opposite Plexiglas 
walls. Time spent in each compartment began recording immediately at the start of each session. A 
rat was considered to have switched sides if the second closest and the closest infrared beams 
relative to the center door on one side were broken, in that order, followed by the occlusion of the 
same beams on the alternate side but in the opposite order. After a rat was considered to have 
switched sides, the recording of amount of time spent on the newly occupied side commenced.  
Nicotine hydrochloride tartrate (Sigma, St. Louis, MO, USA) was dissolved in saline (0.9% 
NaCl) and adjusted to a pH of 7.2.  Both nicotine and saline were administered subcutaneously (s.c.) 
in a volume of 1 ml/kg. Nicotine doses (0.0 (saline), 0.1, 0.3, and 0.6 mg/kg) were expressed as the 
freebase weight. Doses were chosen based upon previous studies showing that they supported 
nicotine CPP in adolescent male rats [19].  
The CPP procedure consisted of four phases: acclimation, baseline, conditioning, and test. 
During acclimation (Day 1; PND 29), rats were placed in the CPP chamber with the guillotine door 
raised and allowed to explore both compartments for 20 min. Rats were initially placed randomly on 
either the left or right side, with half of each treatment group placed on either side.  Two acclimation 
sessions were conducted on Day 1, separated by 4 h; rats were placed back in their home cage and 
returned to the colony room between acclimation sessions. During the second acclimation session, 
rats were placed on the side opposite of where they were initially placed for the first acclimation 
session. 
During baseline assessment (Day 2), rats received saline injections (s.c.) immediately prior to 
each of two 10-min sessions. In all other respects, baseline sessions were identical to acclimation 
sessions. The amount of time spent in each compartment pooled across baseline sessions was used 
to determine potential side bias and subsequent drug-side pairing assignments. Rats that spent less 
than 350 s (out of 1200 s) in either compartment during baseline were excluded from further testing 
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and their baseline data were excluded from analysis. Using this criterion, 1 SHR and 5 WKY rats 
were excluded from analysis. 
During conditioning (Days 3-6), rats were injected (s.c.) with either nicotine (0.1, 0.3 or 0.6 
mg/kg; n = 10-12/dose/strain) or saline once daily, and confined to one compartment for 20 min. A 
biased design was used, such that nicotine or saline (0.0 mg/kg) was paired with the compartment 
that was less preferred during baseline (Nicotine-Paired compartment), and saline was always paired 
with the compartment that was preferred during baseline (Saline-Paired compartment). Rats 
underwent 4 conditioning sessions (2 Nicotine-Paired and 2 Saline-Paired) alternating across 4 days 
in a counterbalanced order.  
 During a single 20-min test session (Day 7), rats received no injections prior to being placed in 
the CPP chamber. Half of the rats in each strain were initially placed in the preferred compartment 
and half were placed in the non-preferred compartment. The guillotine door was raised and 
movement within each compartment was recorded.   
 Difference scores (time spent on the non-preferred side during test minus time spent on the 
non-preferred side during baseline) were calculated for each animal. Nicotine CPP was defined as 
difference scores that were significantly greater for the groups receiving nicotine injections than for 
the group receiving saline throughout conditioning. Because an independent t-test conducted on pre-
test data revealed a significant strain effect in time spent in the Nicotine-Paired compartment (t (42) = 
3.18, p = 0.003; Figure 1), difference scores were analyzed separately for each strain in order to 
ensure that baseline differences did not interfere with the ability to detect positive results. Dunnett’s 
multiple comparisons tests [21] were implemented to compare difference scores for all groups within 
each strain.  
SHR rats in the 0.6 mg/kg group had significantly greater difference scores than SHRs 
receiving saline (p = 0.036) (Figure 1), indicating that SHRs developed nicotine CPP to the highest 
dose tested. In contrast, WKYs did not demonstrate nicotine CPP at any dose tested (all p’s > 0.05). 
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These CPP data should be interpreted with caution. Difference scores, which were the primary 
measure of CPP, are directly affected by pre-test compartment biases, which differed significantly 
between strains. SHRs and WKYs that received saline spent nearly the same amount of time in the 
Nicotine-Paired compartment during test (582 s and 589 s, respectively), yet WKY difference scores 
were 2.5 times greater than SHR difference scores, because of strain differences in baseline time 
spent in the Nicotine-Paired compartment. WKYs receiving nicotine also demonstrated a strong 
baseline compartment bias, which interfered with the interpretation of results by reducing confidence 
that increases in time spent in the Nicotine-Paired compartment were drug-induced and not due to a 
regression-to-the-mean effect. Because the SHRs showed a lower baseline compartment bias, 
regression-to-the-mean interpretations were less of a concern for this strain.  
In WKYs, the lowest nicotine dose (0.1 mg/kg) induced the largest difference scores and the 
largest amount of time spent in the Nicotine-Paired compartment during post-test of any group tested.  
Although this evidence suggests that WKYs are sensitive to the incentive properties of a low nicotine 
dose, difference scores were not significantly greater than those produced by saline (p > 0.05). These 
findings are consistent with previous investigations showing that WKY rats do not develop nicotine 
CPP [22]. 
Locomotor activity was assessed by calculating the number of beam breaks on the Nicotine-
Paired and Saline-Paired compartments during conditioning sessions. Because an independent t-test 
revealed that baseline locomotor activity was significantly higher for SHRs than for WKYs (t (85) = 
3.48, p < 0.001), locomotor activity was analyzed separately for each strain. Locomotor activity was 
compared across strains during conditioning using two 2 (Compartment) x 2 (first vs. second Training 
Day on a particular compartment) x 4 (Dose) ANOVAs. For all analyses, the significance criterion was 
set at p = 0.05. Follow up t-tests were only conducted on significant effects. 
ANOVA conducted on SHR beam breaks revealed a significant Compartment x Day x Dose 
interaction effect (F (3,39) = 2.997, p = 0.042; Figure 2). Follow-up 2 (Compartment) x 4 (Dose) 
ANOVAs conducted on each conditioning day revealed that SHRs made significantly more beam 
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breaks in the Nicotine-Paired compartment than in the Saline-Paired compartment across Day 1 (F 
(1,39) = 12.966, p = .001) and Day 2 (F (1,39) = 8.586, p = .006). Follow-up 2 (Day) x 2 
(Compartment) ANOVAs conducted at each Dose level revealed a significant main effect of Day for 
SHRs receiving the 0.1 mg/kg (F (1,10) = 18.609, p = .002) and 0.3 mg/kg (F (1,10) = 6.339, p = .031) 
doses of nicotine, with more beam breaks on Day 2 than Day 1 (0.1 mg/kg: p = .002; 0.3 mg/kg: p = 
.031). For SHRs receiving the 0.6 mg/kg dose, there was a significant main effect of Compartment (F 
(1,9) = 5.634, p = .042) and Day (F (1,9) = 13.534, p = .005). Pairwise comparisons showed that 
SHRs in the 0.6 mg/kg group made significantly more beam breaks in the Nicotine-Paired 
compartment (p = .042) and on Day 2 (p = .005). Follow-up 2 (Day) x 4 (Dose) ANOVAs conducted 
for each compartment revealed a significant Day x Dose interaction effect (F (3,39) = 3.626, p = .021) 
in the Nicotine-Paired compartment. Paired samples t-tests comparing Nicotine-Paired compartment 
beam breaks between Day 1 and Day 2 at each dose revealed no significant difference across days 
in SHRs receiving saline (t (10) = .357, p = .729). However, Nicotine-Paired compartment beam 
breaks increased significantly from Day 1 to Day 2 for SHRs receiving the 0.1 mg/kg (t (10) = 2.620, p 
= .026), 0.3 mg/kg (t (10) = 2.427, p = .036), and 0.6 mg/kg (t (9) = 4.473, p = .002) nicotine doses. 
The ANOVA conducted on Saline-Paired compartment trials revealed a significant main effect of Day 
(F (1,39) = 18.768, p < .001) with significantly more beam breaks occurring in the Saline-Paired 
compartment on Day 2 than on Day 1 (p < .001). ANOVA conducted on WKY beam breaks only 
revealed a significant main effect of Day (F (1,39) = 5.941, p = 0.019) with more beam beaks 
occurring on the second conditioning trial than the first (p = .019) (see Figure 3).  
Consistent with previous investigations, the present locomotor data suggest that adolescent 
SHRs are significantly more active than WKYs [15]. SHRs are also differentially sensitive to the 
locomotor stimulatory properties of nicotine. During conditioning, SHRs receiving the highest nicotine 
dose (0.6 mg/kg) were more active in the Nicotine-Paired compartment following nicotine injections 
than in the Saline-Paired compartment. Although generalized locomotion (in both Nicotine-Paired and 
Saline-Paired compartments) increased significantly for both strains between conditioning days 1 and 
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2, for SHRs this increase was selective to rats exposed to nicotine. Because the effect of conditioning 
day on locomotion was not specific to the Nicotine-Paired compartment or to the WKY rats that were 
exposed to nicotine, the change in WKY locomotion across days may reflect acclimation to 
conditioning contexts. In contrast, the selective effect of conditioning day on nicotine-exposed SHR 
rats suggests the strengthening of a nicotine-context association that may have partially generalized 
across contexts. 
This study replicates strain effects in the locomotor behavior of adolescent rats, and suggests 
that SHRs display enhanced nicotine-induced place preference and locomotion. These results are 
consistent with a heightened responsiveness to the rewarding properties of nicotine in an animal 
model of ADHD, thus indicating a potential model for ADHD-related increased prevalence of tobacco 
use and dependence. This interpretation of the data is also consistent with reports from clinical cases 
[11, 12] and self-administration data from SHR rats [18]. Nonetheless, this interpretation should be 
considered preliminary. Differences in baseline place preference and locomotion between strains may 
have contributed to differences in nicotine effects. It is also likely that pseudo-conditioning to saline 
obscured nicotine-induced place preference in WKYs. Finally, CPP performance is not solely 
dependent on the rewarding properties of the drug; for instance, place preference may be 
confounded with other behavior induced by the context-drug association [24]. In short, although the 
present results suggest that an animal model of ADHD shows an enhanced responsiveness to 
nicotine, further confidence in such inference requires converging evidence from other behavioral 
paradigms, as well as other animal models of ADHD.  
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Figure Captions 
Figure 1. Mean amount of time spent on the Nicotine-Paired compartment during baseline (white 
bars) and test (black bars) by each SHR (top panel) and WKY (bottom panel) nicotine dose group. 
Error bars represent SEM. The dashed horizontal line indicates half of the session duration. The 
asterisk (*) indicates difference scores (test – baseline) significantly greater than those of the 0.0-
mg/kg (saline) group (p < 0.05). n = 10-11 rats per dose per strain. 
Figure 2. Mean beam breaks of SHR nicotine dose groups on the Nicotine-Paired compartment (left 
panel) and the Saline-Paired compartment (right panel). Error bars represent SEM. # denotes a 
significant effect of compartment. * denotes a significant effect of conditioning trial. 
Figure 3. Mean beam breaks of WKY nicotine groups on the Nicotine-Paired compartment (left 
panel) and Saline-Paired compartment (right panel). Error bars represent SEM. * denotes a 
significant effect of conditioning trial. 
 
 
 
